Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Vivozon Pharmaceutical Revenue

In the year 2025, Vivozon Pharmaceutical had annual revenue of 59.34B KRW, down -32.26%. Vivozon Pharmaceutical had revenue of 16.20B in the quarter ending December 31, 2025, a decrease of -30.33%.

• Revenue: 59.34B
• Revenue Growth: -32.26%
• P/S Ratio: 2.69
• Revenue / Employee: 193.30M
• Employees: n/a
• Market Cap: 159.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	59.34B	-28.26B	-32.26%
Dec 31, 2024	87.60B	16.28B	22.83%
Dec 31, 2023	71.32B	19.75B	38.31%
Dec 31, 2022	51.56B	-6.00B	-10.42%
Dec 31, 2021	57.56B	13.97B	32.04%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error